Treatment of gastroduodenal ulcers with cimetidine in combination with low-dose propantheline

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Treatment of gastroduodenal ulcers with cimetidine in combination with low-dose propantheline. / Paerregaard, A; Hendel, L; Schultz-Larsen, K; Tobiasen, K; Mosbech, J.

I: Journal of Internal Medicine, Bind 213, Nr. 3, 1983, s. 195-8.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Paerregaard, A, Hendel, L, Schultz-Larsen, K, Tobiasen, K & Mosbech, J 1983, 'Treatment of gastroduodenal ulcers with cimetidine in combination with low-dose propantheline', Journal of Internal Medicine, bind 213, nr. 3, s. 195-8.

APA

Paerregaard, A., Hendel, L., Schultz-Larsen, K., Tobiasen, K., & Mosbech, J. (1983). Treatment of gastroduodenal ulcers with cimetidine in combination with low-dose propantheline. Journal of Internal Medicine, 213(3), 195-8.

Vancouver

Paerregaard A, Hendel L, Schultz-Larsen K, Tobiasen K, Mosbech J. Treatment of gastroduodenal ulcers with cimetidine in combination with low-dose propantheline. Journal of Internal Medicine. 1983;213(3):195-8.

Author

Paerregaard, A ; Hendel, L ; Schultz-Larsen, K ; Tobiasen, K ; Mosbech, J. / Treatment of gastroduodenal ulcers with cimetidine in combination with low-dose propantheline. I: Journal of Internal Medicine. 1983 ; Bind 213, Nr. 3. s. 195-8.

Bibtex

@article{6d6b7a20c2cc11dd8ca2000ea68e967b,
title = "Treatment of gastroduodenal ulcers with cimetidine in combination with low-dose propantheline",
abstract = "Fifty-eight adult outpatients with endoscopically verified gastric, prepyloric or duodenal ulcers completed a double-blind trial of treatment with either cimetidine, 1 g daily, plus propantheline, 45 mg daily (group A) or cimetidine, 1 g daily, plus placebo (group B). After neither three nor six weeks of treatment was there any significant difference between the two groups with regard to ulcer healing or symptomatic relief. The ulcers of 22 (79%) of the 28 patients in group A and 25 (83%) of the 30 patients in group B were healed after six weeks, and 93% of the patients in both groups became painfree. We were thus not able to show any advantage in combining cimetidine treatment for ulcer healing with low-dose propantheline. In a small open trial the patients with healed ulcers received prophylactic treatment for 12 months with 1) cimetidine 800 mg daily, 2) cimetidine 400 mg at bedtime plus propantheline 45 mg daily or 3) propantheline 90 mg daily. No significant differences were found between the ulcer recurrence rates, but it cannot be excluded that a larger number of patients in each group might have yielded real differences.",
author = "A Paerregaard and L Hendel and K Schultz-Larsen and K Tobiasen and J Mosbech",
note = "Keywords: Adolescent; Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Guanidines; Humans; Male; Middle Aged; Propantheline; Stomach Ulcer",
year = "1983",
language = "English",
volume = "213",
pages = "195--8",
journal = "Acta Medica Scandinavica",
issn = "0955-7873",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - Treatment of gastroduodenal ulcers with cimetidine in combination with low-dose propantheline

AU - Paerregaard, A

AU - Hendel, L

AU - Schultz-Larsen, K

AU - Tobiasen, K

AU - Mosbech, J

N1 - Keywords: Adolescent; Adult; Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Guanidines; Humans; Male; Middle Aged; Propantheline; Stomach Ulcer

PY - 1983

Y1 - 1983

N2 - Fifty-eight adult outpatients with endoscopically verified gastric, prepyloric or duodenal ulcers completed a double-blind trial of treatment with either cimetidine, 1 g daily, plus propantheline, 45 mg daily (group A) or cimetidine, 1 g daily, plus placebo (group B). After neither three nor six weeks of treatment was there any significant difference between the two groups with regard to ulcer healing or symptomatic relief. The ulcers of 22 (79%) of the 28 patients in group A and 25 (83%) of the 30 patients in group B were healed after six weeks, and 93% of the patients in both groups became painfree. We were thus not able to show any advantage in combining cimetidine treatment for ulcer healing with low-dose propantheline. In a small open trial the patients with healed ulcers received prophylactic treatment for 12 months with 1) cimetidine 800 mg daily, 2) cimetidine 400 mg at bedtime plus propantheline 45 mg daily or 3) propantheline 90 mg daily. No significant differences were found between the ulcer recurrence rates, but it cannot be excluded that a larger number of patients in each group might have yielded real differences.

AB - Fifty-eight adult outpatients with endoscopically verified gastric, prepyloric or duodenal ulcers completed a double-blind trial of treatment with either cimetidine, 1 g daily, plus propantheline, 45 mg daily (group A) or cimetidine, 1 g daily, plus placebo (group B). After neither three nor six weeks of treatment was there any significant difference between the two groups with regard to ulcer healing or symptomatic relief. The ulcers of 22 (79%) of the 28 patients in group A and 25 (83%) of the 30 patients in group B were healed after six weeks, and 93% of the patients in both groups became painfree. We were thus not able to show any advantage in combining cimetidine treatment for ulcer healing with low-dose propantheline. In a small open trial the patients with healed ulcers received prophylactic treatment for 12 months with 1) cimetidine 800 mg daily, 2) cimetidine 400 mg at bedtime plus propantheline 45 mg daily or 3) propantheline 90 mg daily. No significant differences were found between the ulcer recurrence rates, but it cannot be excluded that a larger number of patients in each group might have yielded real differences.

M3 - Journal article

C2 - 6342335

VL - 213

SP - 195

EP - 198

JO - Acta Medica Scandinavica

JF - Acta Medica Scandinavica

SN - 0955-7873

IS - 3

ER -

ID: 8876808